Journal List > Korean J Pediatr Gastroenterol Nutr > v.14(Suppl 1) > 1043539

Korean J Pediatr Gastroenterol Nutr. 2011 Dec;14(Suppl 1):S42-S46. Korean.
Published online December 31, 2011.  https://doi.org/10.5223/kjpgn.2011.14.Suppl1.S42
Copyright © 2011 The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition
Stem Cell in Pediatric Gastrointestinal Tract Disease: Hirschsprung Disease
Sun Hwan Bae, M.D., Ph.D.
Department of Pediatrics, Konkuk University School of Medicine, Seoul, Korea.

Corresponding author (Email: baedori@hanafos.com )
Received December 24, 2011; Revised December 29, 2011; Accepted December 29, 2011.

Abstract

Stem cell is characterized with self-renewal and mult-potency. Many pediatric gastrointestinal diseases have defect in enterocytes, enteric nervous system, and Interstitial cell of Cajal. Various kinds of stem cell could be applied to these diseases. Here, the author introduces stem cell for pediatric gastrointestinal diseases, particularly Hirschsprung disease.

Keywords: Stem cell; Hirschsprung disease

Figures


Fig. 1
Lineage tracing in the small intestine confirms intestinal stem cells. In this case, LacZ activity was used as a reporter gene8).
Click for larger image


Fig. 2
Neurons from transplanted neurospheres regulate the contractility of developing gut. EMNS and NHNS transplanted bowel have comparable contraction frequencies to ganglionic distal colon, but have significantly lower contraction frequencies than aganglionic distal colon, demonstrating a functional effect of neurosphere transplantation18). EMNS: aganglionic distal colon transplanted with embryonic mouse neurosphere, NHNS: aganglionic distal colon transplanted with neonatal human neurosphere, TTX: tetrodotoxin.
Click for larger image

References
1. Quante M, Wang TC. Stem cell in gastroenterology and hepatology. Nat Rev Gastroenterol Hepatol 2009;6:724–737.
2. Mills JC, Shivdasani RA. Gastric epitheilial stem cell. Gastroenterology 2011;140:412–424.
3. Malgieri A, Kantzari E, Patrizi MP, Gambardella S. Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art. Int J Clin Exp Med 2010;3:248–269.
4. Barker N, De Wetering MV, Clvers H. The intestinal stem cell. Genes Dev 2008;22:1856–1864.
5. Takeda N, Jain R, LeBoeuf MR, Wang Q, Lu MM, Epstein JA. Interconversion between intestinal stem cell populations in distinct niches. Science 2011;334:1420–1424.
6. Sato T, Van Es JH, Snippert HJ, Stange DE, Vries RG, van den Born M, et al. Paneth cells constitute the niche for Lgr5 stem cells in the intestinal crypts. Nature 2011;469:415–418.
7. Kelly PN, Dakic A, Adams M, Nutt SL, Strasser A. Tumor growth need not be driven by rare cancer stem cell. Science 2007;317:337.
8. Snippert HJ, Van Es JV, van den Born M, Begthel H, Stange DE, Barker N, et al. promin-1/CD133 marks stem cells and early progenitors in mouse small intestine. Gastroenterology 2009;136:2187–2194.e1.
9. Umar S. Intestinal stem cells. Curr Gastroenterol Rep 2010;12:340–348.
10. Meirelles Lda S, Fontes AM, Covas DT, Caplan AI. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 2009;20:419–427.
11. Shi Y, Hu G, Su J, Li W, Chen Q, Shou P, et al. Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Research 2010;20:510–518.
12. Kuo TK, Hung SP, Chuang CH, Chen CT, Shih YR, Fang SC, et al. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 2008;134:2111–2121.
13. Brittan M, Alison MR, Schier S, Wright NA. Bone marrow stem cell-mediated regeneration in IBD: where do we go from here? Gastroenterology 2007;132:1171–1173.
14. Kapur RP. Hirschsprung disease and other enteric dysgangliosis. Crit Rev Clin Lab Sci 1999;36:225–273.
15. Almond S, Lindley RM, Kenny SE, Connell MG, Edgar DH. Characterisation and transplantation of enteric nervous system progenitor cells. Gut 2007;56:489–496.
16. Metzger M, Bareiss PM, Danker T, Wagner S, Hennelotter J, Guenther E, et al. Expansion and differentiation of neural progenitors derived from the human adult enteric nervous system. Gastroenterology 2009;137:2063–2073.
17. Metzger M, Cadwell C, Barlow AJ, Burns AJ, Thapar N. Enteric nervous system stem cells derived from human gut mucosa for the treatment of aganglionic gut disorders. Gastroenterology 2009;136:2214–2225.
18. Lindley RM, Hawcutt DB, Connell MG, Almond SN, Vannucchi MG, Simonetta M, et al. Human and mouse enteric nervous system neurosphere transplants regulate the function of aganglionic embryonic distal colon. Gastroenterology 2008;135:205–216.